Boston Scientific to Acquire Preventice Solutions for $925 Million

January 22, 2021

Boston Scientific entered into a definitive agreement to acquire Preventice Solutions, a private provider of mobile cardiac health monitoring solutions and services, for an upfront cash payment of $925 million. The deal also includes up to $300 million in potential commercial milestone payments and is expected to close by mid-2021 subject to customary conditions.

Targets
Preventice Solutions
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.